Foto del docente

Matteo Pavoni

Assegnista di ricerca

Dipartimento di Scienze Mediche e Chirurgiche

Curriculum vitae

Scarica Curriculum Vitae (.pdf 197KB )

MATTEO PAVONI

Cittadinanza: Italiana

Data di nascita: 06/02/1993

Sesso: Maschile

FORMAZIONE

Specializzando in Microbiologia e Virologia nel 2019 presso l’Università La Sapienza di Roma. Abilitazione all'esercizio della professione di Biologo, Università Politecnica delle Marche. Laurea in Biologia della salute (LM-6) presso l'Università degli Studi di Bologna 2017. Laurea triennale in Scienze Biologiche (L-13) presso l'Università Politecnica delle Marche 2015.

ATTIVITA' SCIENTIFICA

PUBBLICAZIONI SCIENTIFICHE EDITE DA PUBMED

  1. De Francesco, Vincenzo; Zullo, Angelo; Fiorini, Giulia; Saracino, Ilaria; Pavoni, Matteo; Vaira, Dino. Role of minimal inhibitor concentration (MIC) levels towards clarithromycin and metronidazole resistance on H. pylori eradication. J Antimicrob Chemother. 2019 Mar 1;74(3):772-774. (I.F.5.2
  2. Fiorini G, Saracino IM, Zullo A, Gatta L, Pavoni M, Vaira D.  Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori- resistant strains.  Helicobacter 2017;22; .(I.F. 3.4).
  3. Ilaria Maria Saracino, Matteo Pavoni, Laura Saccomanno, Giulia Fiorini,

    Valeria Pesci, Claudio Foschi, Giulia Piccirilli, Giulia Bernardini , John Holton,

    Natale Figura, Tiziana Lazzarotto, Claudio Borghi and Berardino Vaira

    Antimicrobial efficacy of five probiotic strains against Helicobacter pylori.Antibiotics 2020, 9(5), 244. (I.F. 2.9)

  4. Fiorini G, Zullo A, Saracino IM, Pavoni M, Vaira D. Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016. Scan J Gastroenterol 2018 JUN (53): 6 661-664 (I.F. 2.3)
  5. Ferdinando D’Amico, Giulia Fiorini, Antonio Tursi, Ilaria Maria Saracino, Matteo Pavoni, Silvio Danese, Dino Vaira. Efficacy of a new nutraceutical formulation in patients with symptomatic uncomplicated diverticular disease (SUDD): A prospective observational study. 2019 Journal of Gastrointestinal and Liver Diseases 28, pp. 49-52. (I.F. 2.1).

  6. Saracino I.M., Fiorini G., Zullo A., Pavoni M., Saccomanno L. and Vaira D. Trends in Primary Antibiotic Resistance in H.pylori Strains isolated in Italy between 2009 and 2019.

    Antibiotics 2020, 9(1), 26. (IF 2.9)

  7. A.Zullo, G.Fiorini, G.Bassotti, F.Bachetti, F.Monica, D.Macor, A.O.Paoluzi, G.Scaccianoce, P.Porticasa, V.DeFrancesco, R.Lorenzetti, I.M.Saracino, M.Pavoni, D.Vaira. Upper endoscopy in patients with extra-oesophageal reflux symptoms: a multicenter study. Portuguese journal of Gastroenterology in press (IF 0.47)

  8. Pavoni M*., Saracino IM*., Zullo A., Fiorini G., Saccomanno L., Lazzarotto T., Cavallo R., Antonelli G., Vaira D. Antibiotic resistance and therapy outcome in H.pylori eradication failure patients.

    Antibiotics 2020 Mar 13;9(3):121 (IF 2.9)

  9. Fiorini G., Saracino I.M Pavoni M. Saccomanno L Vaira D. Efficacy of a new nutraceutical formulation (CHETOGERD) in patients with nonerosive reflux (NERD): a prospective observational study.

    Intern Emerg Med. 2017;12: 333-39. 2020 (I.F. 2.5).

  10. Fiorini G., Zullo A., Saracino I.M., Gatta L., Pavoni M., Vaira D.

    Pylera and sequential therapy for first-line H. pylori eradication: a culture-based study in real clinical pactice. European Journal of Gastroenterology & Hepatology 2018; 30; 621-25. (I.F.2)

  11. Ilaria M.Saracino†, MatteoPavoni†, AngeloZullo, GiuliaFiorini, LauraSaccomanno, TizianaLazzarotto, GuidoAntonelli, RossanaCavallo, ClaudioBorghi, DinoVaira.

    Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection. European Journal of Internal Medicine in press (I.F. 3.66)

PUBBLICAZIONI IN ITALIANO

  1. Giulia Fiorini, Ilaria Maria Saracino, Laura Saccomanno, Matteo Pavoni, Dino Vaira.

    Efficacia del bifidobacterium breve e del Lactobacillus Rhamnosus come coadiuvanti nell’eradicazione dell’Helicobacter pylori in pazienti naive.

    FARMACI 2017 vol 16 pg 1-8

    ABSTRACT ACCETTATI COME ORAL PRESENTATION IN CONGRESSI INTERNAZIONALI

  1. Oral Presentation Saracino I.M., Pavoni M., Fiorini G., Saccomanno L., Bibbs D.,Vaira D.

    Evaluation of Curian HpSA Fluorometric assay. A novel, rapid immunoassay for the dectection of Helicobacter pylori antigens in human stool.

    Kaunas 2018 Abstract W1.1 Helicobacter 23 (suppl 1) 31° International Workshop on Helicobacter& Microbiota in Inflammation & Cancer

    Presenting author: Matteo Pavoni

  2. Oral Comunication G. Fiorini, A. Zullo, I.M. Saracino, L. Gatta, M. Pavoni, B. Vaira. PYLERA AND SEQUENTIAL THERAPY FOR FIRST-LINE H. PYLORI ERADICATION: A CULTURE-BASED STUDY IN REAL CLINICAL PRACTICE 24° CNMD FISMAD 21-24 marzo 2018, Roma March 2018 OC.14.5, Digestive and Liver Disease 50(2):e105

  3. Oral Communication Pavoni M., Turello G., Saracino I.M., Fiorini G., Saccomanno L., Lazzarotto T., Vaira B., Beckman E. PCR Test for Helicobacter pylori detection and Clarithromycin Resistance prediction on fecal and bioptic samples: comparison of accuracies. 25° CNMD FISMAD 27-30 marzo 2019, Roma. Digestive and Liver Disease, Volume 51, Supplement 2, 25 March 2019, Pages e106-e107

  4. Oral Communication Zagari, R; Romiti, A; Fiorini, G; Saracino, I; Ribaldone, D; Panarese, A; Lella, F; Gigliotti, F; Gasbarrini, A; Paoluzi, O; Blanco, GD; Romano, M; Annibale, B; Broglia, L; Catanzaro, R; Hervoso, CM; Luzza, F; Nardone, G; Conigliaro, R; Cannizzaro, R; Pavoni, M; Vaira, B; Pellicano, R; Ferrara, M; Bazzoli, F. XXXIInd Workshop of the European Helicobacter and Microbiota Study Group Use of probiotics in the Helicobacter pylori eradication in Italy: data from the Italian Registry on Helicobacter pylori treatment Helicobacter vol 24 suppl 1, 38-39

  5. Oral Comunication. Pavoni M., Turello G., Saracino I.M., Fiorini G., Saccomanno L., Lazzarotto T., Vaira B., Beckman E.

    PCR Test for Helicobacter pylori detection and Clarithromycin Resistance prediction on fecal and bioptic samples: comparison of accuracies. 119° Congresso SIMI Roma 26-28 ottobre 2018

    October 2018 Internal and emergency medicine [in press]

  6. Oral presentation Pavoni M., Turello G., Saracino I.M., Fiorini G., Saccomanno L., Lazzarotto T., Vaira B., Beckman E.

    PCR Test for Helicobacter pylori detection and Clarithromycin Resistance prediction on fecal and bioptic samples: comparison of accuracies. UEG week 2018. 20-24 ottobre, Vienna. UEG journal 2018: 6 (8S) pg A64

    ABSTRACT ACCETTATI COME POSTER PRESENTATION IN CONGRESSI INTERNAZIONALI

  1. Poster presentation Pavoni M., Turello G., Saracino I.M., Fiorini G., Saccomanno L., Lazzarotto T., Vaira B., Beckman E.

    PCR Test for Helicobacter pylori detection and Clarithromycin Resistance prediction on fecal and bioptic samples: comparison of accuracies.

    Kaunas 2018 Poster P01.18 Helicobacter 23 (suppl 1) 31° International Workshop on Helicobacter& Microbiota in Inflammation & Cancer

  2. Poster presentation G.Fiorini, I.M.Saracino, A.Zullo, L.Gatta, M.Pavoni, D.Vaira.

    Rescue therapy with bismuth quadruple regimen in patients with H. pylori resistant strains.

    Kaunas 2018 Poster P02.35 Helicobacter 23 (suppl 1) 31° International Workshop on Helicobacter& Microbiota in Inflammation & Cancer

  3. Poster presentation G.Fiorini, A.Zullo, I.M.Saracino, L.Gatta, M.Pavoni, D.Vaira.

    Pylera and sequential therapy for first-line H. pylori eradication: a culture-based study in real clinicalpractice.

    Kaunas 2018 Poster P06.14 Helicobacter 23 (suppl 1). 31° International Workshop on Helicobacter& Microbiota in Inflammation & Cancer

  4. Poster presentation G. Fiorini, I.M. Saracino, L. Saccomanno, M. Pavoni, B. Vaira.

    BIFIDOBACTERIUM BREVE AND LACTOBACILLUS RHAMNOSUS EFFICACY AS COADJUVANTS IN THE HELICOBACTER PYLORI ERADICATION IN NAÏVE PATIENTS. March 2018,Poster P.06.7 Digestive and Liver Disease 50(2):e181

  5. Poster presentation F. D’Amico, G. Fiorini, A. Turisi, I.M. Saracino, M. Pavoni, S. Danese, D. Vaira. EFFICACY OF DIVER-100 IN PATIENTS WITH SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE (SUDD): PRELIMINARY RESULTS FROM A PROSPECTIVE OBSERVATIONAL COHORT. March 2018, Poster P.05.17, Digestive and Liver Disease 50(2):e172-e173.

  6. Poster presentation G. Fiorini, I.M. Saracino, A. Zullo, L. Gatta, M. Pavoni, B. Vaira. RESCUE THERAPY WITH BISMUTH QUADRUPLE REGIMEN IN PATIENTS WITH HELICOBACTER PYLORI -RESISTANT STRAINS. March 2018, Poster P.10.10 Digestive and Liver Disease 50(2):e232.

  7. Poster presentation G. Fiorini, A. Zullo, I.M. Saracino, L. Gatta, M. Pavoni, B. Vaira. H. PYLORI RESISTANCE STATUS AND EFFICACY OF SEQUENTIAL THERAPY FOR FIRST-LINE THERAPY: A 6-YEAR EXPERIENCE IN A SINGLE ITALIAN CENTER. March 2018 Poster P.01.21, Digestive and Liver Disease 50(2):e128

  8. Poster Presentation Saracino I.M., Pavoni M., Fiorini G., Saccomanno L., Bibbs D.,Vaira D. Evaluation of Curian HpSA Fluorometric assay. A novel, rapid immunoassay for the dectection of Helicobacter pylori antigens in human stool.

    UEG journal 2018 6(8S) pgA528

  9. Poster presentation G.Fiorini, A.Zullo, I.M.Saracino, L.Gatta, M.Pavoni, D.Vaira. Pylera and sequential therapy for first-line H. pylori eradication: a culture-based study in real clinicalpractice.

    UEG journal 2018 6(8S) pgA730

  10. Poster presentation G.Fiorini, I.M.Saracino, A. Zullo, L.Gatta, M.Pavoni, D.Vaira. Bismuth quadruple regimen as rescue therapy in patients with Helicobacter Pylori-resistant strains

    UEG journal 2018 6(8S)

  11. 25° CNMD FISMAD 27-30 Marzo 2019 Roma. I.M. Saracino, M. Pavoni, G. Fiorini, L. Saccomanno, D. Bibbs, B. Vaira Evaluation of Curian HpSA fluorimetric assay, a novel, rapid immunoassay for the detection of Helicobacter pylori antigens in human stool.

    Digestive and liver disease Volume 51, Supplement 2, 25 March 2019, Pages e137-e138

  12. XLVIII CONGRESSO NAZIONALE AMCLI – Rimini, 9-12 novembre 2019 M. Pavoni, L. Saccomanno, I.M. Saracino, G. Fiorini and D. Vaira. COMPARISON OF TRENDS IN ANTIBIOTIC RESISTANCE AND ERADICATION RATES IN H PYLORI STRAINS ISOLATED BETWEEN 2009 AND 2019

  13. 120° Congresso Nazionale SIMI Roma, 18-20 ottobre 2019. Efficacy of a new nutraceutical formulation in Symptomatic Uncomplicated Diverticular Disease: a prospective study F. D’Amico, G. Fiorini, A. Tursi, I. M. Saracino, M. Pavoni, S. Danese, D. Vaira

  14. 120° Congresso Nazionale SIMI Roma, 18-20 ottobre 2019. Prevalence of gastro-oesophageal lesions in patients with atypical reflux symptoms: a multicenter study.

    PREMI

    Premio di ricerca, 119° congresso SIMI, Roma 26-28 ottobre 2018

    Fiorini G., Saracino I.M., Pavoni M., Vaira D.

    Cellule staminali Lgr5+ nel cancro gastrico di tipo intestinale e nelle fasi pre-neoplastiche.

    EVENTI FORMATIVI ECM

  1. Ordine Provinciale dei Medici Chirurghi e degli Odontoiatri di Bologna

    Provider Nazionale n. 3744

    INTEGRATORI ALIMENTARI

    Come reagisce il nostro microbiota intestinale?

    Se e quanto gli integratori alimentari possono rinforzare e proteggere

    il nostro confine intestinale

    Sabato 6 ottobre 2018

    Sala Conferenze del Circolo Ufficiali dell’Esercito

Via Marsala n. 12 Bologna

Ultimi avvisi

Al momento non sono presenti avvisi.